EA202191922A1 - METHODS AND COMPOSITIONS FOR TREATMENT OF MALIGNANT TUMORS - Google Patents

METHODS AND COMPOSITIONS FOR TREATMENT OF MALIGNANT TUMORS

Info

Publication number
EA202191922A1
EA202191922A1 EA202191922A EA202191922A EA202191922A1 EA 202191922 A1 EA202191922 A1 EA 202191922A1 EA 202191922 A EA202191922 A EA 202191922A EA 202191922 A EA202191922 A EA 202191922A EA 202191922 A1 EA202191922 A1 EA 202191922A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
methods
treatment
malignant tumors
cancer
Prior art date
Application number
EA202191922A
Other languages
Russian (ru)
Inventor
Майкл Чичирелли
Нил С. Катшелл
Грегори А. Демопулос
Джордж А. Гаитанарис
Марк А. Гэвин
Александер Грагеров
Томас Л. Литтл
Рене Онраст
Original Assignee
Омерос Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Омерос Корпорейшн filed Critical Омерос Корпорейшн
Priority claimed from PCT/US2020/013183 external-priority patent/WO2020146795A1/en
Publication of EA202191922A1 publication Critical patent/EA202191922A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к соединениям, композициям и способам для лечения различных заболеваний и/или состояний, связанных с сопряженным с G белком рецептором 174 (например, злокачественных опухолей).The present invention relates to compounds, compositions and methods for treating various diseases and / or conditions associated with G protein coupled receptor 174 (eg, cancer).

EA202191922A 2019-12-11 2020-01-10 METHODS AND COMPOSITIONS FOR TREATMENT OF MALIGNANT TUMORS EA202191922A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962946631P 2019-12-11 2019-12-11
PCT/US2020/013183 WO2020146795A1 (en) 2019-01-11 2020-01-10 Methods and compositions for treating cancer

Publications (1)

Publication Number Publication Date
EA202191922A1 true EA202191922A1 (en) 2021-11-15

Family

ID=78768142

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191922A EA202191922A1 (en) 2019-12-11 2020-01-10 METHODS AND COMPOSITIONS FOR TREATMENT OF MALIGNANT TUMORS

Country Status (1)

Country Link
EA (1) EA202191922A1 (en)

Similar Documents

Publication Publication Date Title
JOP20210154B1 (en) Kif18a inhibitors
MX2021007104A (en) Kif18a inhibitors.
ZA202004730B (en) Anti-claudin 18.2 antibodies and uses thereof
EA201990912A1 (en) ANTI-LAG-3 ANTIBODIES AND THEIR COMPOSITIONS
MX2020009366A (en) Anti-cd73 antibodies and uses thereof.
MX2022001181A (en) Kif18a inhibitors.
EA201890730A1 (en) DERIVATIVES OF PYRAZOLOPYRIMIDINE AS BTK INHIBITORS FOR THE TREATMENT OF MALIGNANT NORODUCTURE
EA201892229A1 (en) SUBSTITUTED AMINOPURIN COMPOUNDS CONTAINING THEIR COMPOSITIONS AND TREATMENT METHODS WITH THEIR APPLICATION
EA202092086A1 (en) ARGINASE INHIBITORS
MX2021014286A (en) Multispecific proteins.
MX2021008094A (en) Methods and compositions for treating cancer.
CR20220207A (en) Therapeutic compounds and methods of use
EA202191769A1 (en) TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES
MX2020012281A (en) Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof.
EA202191476A1 (en) HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
EA202092459A1 (en) INTERLEUKIN 12 HYBRID PROTEINS, COMPOSITIONS AND METHODS OF THERAPEUTIC APPLICATION, WHICH INCLUDE THEM
EA202092125A1 (en) ANTIBODIES AGAINST FOLATE 1 RECEPTOR AND THEIR APPLICATION
BR112022008821A2 (en) TYK2 PSEUDOKINASE BINDERS
EA202192488A1 (en) ANTIBODIES AGAINST TSG-6 AND THEIR APPLICATIONS
EA202191058A1 (en) ANTIBODIES AGAINST MUCIN-16 AND METHODS OF THEIR APPLICATION
BR112021017710A2 (en) Compound, pharmaceutical composition, treatment method
EA202092122A1 (en) ANTIBODIES AGAINST TIP-1 AND THEIR APPLICATION
EA202191922A1 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF MALIGNANT TUMORS
ZA202110285B (en) Antibodies and methods of use
MX2021011699A (en) Quinoline derivatives and their use for the treatment of cancer.